Eikon Therapeutics

Eikon Therapeutics

  • Founded: 2019
  • Location: Hayward, CA
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Undisclosed
  • Lead product: Undisclosed
  • Product link: https://www.eikontx.com/pipeline
  • Funding: $106M C Jun 2023; $518M B Jan 2022; $148M A May 2021



job board

Short description:

Single Particle Tracking

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

Eikon Therapeutics is using super-resolution microscopy for drug development. Advances in super-resolution fluorescence microscopy has now made it possible to follow the dynamics of individual proteins in living cells. Measurements from single particle tracking enable the calculation of protein angular movements, on-rates/off-rates and residence times for binding events. Eikon is using this technology to assess protein dynamics and reveal novel biological mechanisms of action, thus providing new therapeutic approaches. This requires the combination of engineering, computation, biology, medicinal chemistry and pharmacology expertise. Eikon’s pipeline is designed to achieve effective therapeutics for unmet medical needs.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com